Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Health Care REIT, Inc.    HCN

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales2 8813 2983 8604 1604 3254 571
Operating income (EBITDA)1 4261 7281 9772 2042 3032 399
Operating profit (EBIT)5618841 1511 1331 2791 401
Pre-Tax Profit (EBT)102-----
Net income78,7447818685761853
P/E ratio19152,229,136,734,029,0
EPS ( $ )0,281,452,341,902,052,40
Dividend per Share ( $ )3,063,183,303,443,573,70
Yield5,71%4,20%4,85%4,94%5,12%5,31%
Reference price ( $ )53.5775.6768.0369.6669.6669.66
Announcement Date02/19/2014
12:30pm
02/20/2015
12:30pm
02/18/2016
01:36pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt--12 53112 14612 82013 163
Finance------
Operating income (EBITDA)1 4261 7281 9772 2042 3032 399
Leverage
(Debt/EBITDA)
--6,34x5,51x5,57x5,49x
Capital Expenditure3 98113364,578,986,291,6
Book Value Per Share (BVPS)41,0 $40,2 $41,3 $44,2 $38,2 $37,0 $
Cash Flow per Share3,55 $3,70 $3,93 $4,27 $4,44 $4,92 $
Announcement Date02/19/2014
12:30pm
02/20/2015
12:30pm
02/18/2016
01:36pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 24 822 M$ -
Entreprise Value (EV) 36 968 M$ 37 642 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 36,7x 34,0x
Capitalization / Revenue 5,97x 5,74x
EV / Revenue 8,89x 8,70x
EV / EBITDA 16,8x 16,3x
Yield (DPS / Price) 4,94% 5,12%
Price to book (Price / BVPS) 1,58x 1,82x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 27,2% 29,6%
operating Leverage (Delta EBIT / Delta Sales) - 3,25x
Net Margin (Net Profit / Revenue) 16,5% 17,6%
ROA (Net Profit / Asset) 2,47% 2,73%
ROE (Net Profit / Equities) 5,29% 6,10%
Rate of Dividend 181% 174%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   1,90% 1,99%
Cash Flow / Sales 36,5% 36,5%
Capital Intensity (Assets / Sales) 6,68x 6,44x
Financial Leverage (Net Debt / EBITDA) 5,51x 5,57x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend